The researchers, from Northwest A&F University in China, used a modified version of the CRISPR gene-editing technology to insert a new gene into the cow genome with no detected off target effects on the animals genetics - a common problem when creating transgenic animals using CRISPR.
"We used a novel version of the CRISPR system called CRISPR/Cas9n to successfully insert a tuberculosis resistance gene, called NRAMP1, into the cow genome," lead researcher Yong Zhang said.
"We were then able to successfully develop live cows carrying increased resistance to tuberculosis. Importantly, our method produced no off target effects on the cow genetics meaning that the CRISPR technology we employed may be better suited to producing transgenic livestock with purposefully manipulated genetics," said Zhang.
However, sometimes unintentional changes to the genetic code occur as an off target effect, so finding ways to reduce these is a priority for genomics research.
Also Read
"We employed a meticulous and methodological approach to identify the best suited region for gene insertion, which we show has no detectable off target effects on the bovine genome," Zhang said.
The researchers inserted the NRAMP1 gene into the genome of bovine foetal fibroblasts - a cell derived from female dairy cows-using the CRISPR/Cas9n technology.
Ova were nurtured in the lab into embryos before being transferred into mother cows for a normal pregnancy cycle. The experiments were also conducted using the standard CRISPR/Cas9 technology as a comparison.
The total of 11 calves with new genes inserted using CRISPR were able to be assessed for resistance to tuberculosis and any off target genetic effects.
Genetic analysis of the calves revealed that NRAMP1 had successfully integrated into the genetic code at the targeted region in all of the calves.
When the calves were exposed to M bovis, the bacterium that causes bovine tuberculosis, the researchers found that transgenic animals showed an increased resistance to bacteria measured by standard markers of infection in a blood sample.
The research was published in the journal Genome Biology.
Disclaimer: No Business Standard Journalist was involved in creation of this content